Todas las investigaciones
Activo, no reclutandoFASE3INTERVENCIONISTA

A Study of Navenibart in Participants With Hereditary Angioedema

This research study, called a Phase 3 trial, is looking at a new medicine called navenibart for people who have Hereditary Angioedema (HAE). HAE is a rare condition that causes sudden swelling attacks. The main goal is to find out if navenibart can safely and effectively stop these swelling attacks from happening in both adults and teenagers. Some participants will receive navenibart, while others will receive a placebo (a dummy treatment with no active medicine). This helps researchers compare the effects fairly. It’s a ‘double-blind’ study, meaning neither the participants nor the doctors will know who is getting the actual medicine and who is getting the placebo.

De un vistazo

Estado
Activo, no reclutando
Fase
FASE3
Patrocinador
Astria Therapeutics, Inc.
Objetivo de inscripción
157
Inicio
20 Mar 2025
Estimación de finalización
01 Jun 2027

¿De qué trata este estudio?

This important study is testing a new treatment called navenibart for a condition known as Hereditary Angioedema, often shortened to HAE. HAE is a genetic condition that causes sudden, unpredictable swelling attacks in different parts of the body, such as the skin, stomach, or throat. These attacks can be painful, debilitating, and sometimes even life-threatening, especially if the swelling affects the airways.

The main aim of this study is to see if navenibart can help prevent these swelling attacks from happening. Researchers are also very keen to understand if the medicine is safe. They will compare navenibart with a 'placebo' – which looks just like the real medicine but contains no active ingredients. This is a standard way to find out if the new medicine really works better than no treatment.

This study is a 'Phase 3' trial, which means it's one of the final steps before a new medicine might be approved for wider use. It involves many medical centres and participants, carefully looking at how navenibart works in adults and teenagers who have HAE type 1 or type 2. If successful, navenibart could offer a new way to help manage HAE and improve the lives of those affected.

Puntos clave

  • This study is testing a new medicine, navenibart, for Hereditary Angioedema (HAE).
  • Its main goal is to prevent HAE swelling attacks in adults and teenagers.
  • Participants will receive either navenibart or a placebo (dummy treatment).
  • It's a 'Phase 3' study, aiming to confirm safety and effectiveness.
  • Regular clinic visits and self-monitoring of HAE attacks will be required.

¿Quién puede ser elegible?

To join this study, you must have a confirmed diagnosis of Hereditary Angioedema (HAE), either type 1 or type 2. This means your doctor will have found evidence of HAE from your medical history and specific blood tests.

During a short period before the main study, called a 'run-in' period, you would have needed to experience at least two HAE swelling attacks. This helps the researchers understand your typical attack pattern before you start any new treatment.

There are also some reasons why you wouldn't be able to join. For example, if you have other types of swelling conditions that mimic HAE, or if you've recently used certain other medicines for preventing HAE attacks. You would need to stop these other preventative medicines for a set time before the study begins, under the guidance of the study doctors.

¿Podría este estudio ser adecuado para ti?

Responde estas preguntas rápidas para ver si puedes ser elegible. Esto es solo una guía: el equipo de investigación toma la decisión final.

  1. Do you have a doctor-confirmed diagnosis of Hereditary Angioedema (HAE) Type 1 or Type 2?
  2. Have you had at least two HAE attacks recorded by a doctor very recently?
  3. Are you aged 12 years or older?
  4. Do you currently have any other swelling conditions like HAE type 3?
  5. Have you recently used certain other medicines to prevent HAE attacks (your doctor can advise on specific timeframes)?
Responde cada pregunta para ver tu resultado.

¿En qué consiste la participación?

If you join the study, you will receive either the new medicine, navenibart, or a placebo, given as an injection under the skin. You won't know which one you're getting, and neither will your study doctor – this is to make sure the results are as fair and unbiased as possible. Over the course of the study, you'll have regular visits to the clinic so the medical team can monitor your health, check for any side effects, and see how many HAE attacks you experience. You will also need to keep a record of your HAE attacks at home. The total duration of your participation in this study will be explained in detail by the study team, including how often you'll need to attend appointments and how long the treatment period will last, along with any follow-up checks.

Riesgos y beneficios potenciales

Taking part in this study could offer the potential benefit of receiving an experimental treatment that might reduce your HAE attacks. However, there's no guarantee the treatment will work for you, and you might receive a placebo. As with any medication, there's a risk of side effects, which will be carefully monitored by the study team. All potential risks and side effects will be fully explained before you decide to participate. Remember, you can choose to leave the study at any time, for any reason, without it affecting your usual medical care.

Locations (86)

  • Site 9
    Código postal verificado
    Birmingham, United States
  • Site 2
    Código postal verificado
    Scottsdale, Estados Unidos
  • Site 3
    Código postal verificado
    Little Rock, Estados Unidos
  • Site 26
    Código postal verificado
    San Diego, Estados Unidos
  • Site 14
    Código postal verificado
    San Diego, Estados Unidos
  • Site 4
    Código postal verificado
    Santa Mónica, Estados Unidos
  • Site 1
    Código postal verificado
    Walnut Creek, Estados Unidos
  • Site 8
    Código postal verificado
    Centennial, Estados Unidos
  • Site 11
    Código postal verificado
    Colorado Springs, Estados Unidos
  • Site 25
    Código postal verificado
    Tampa, Estados Unidos
  • Site 69
    Código postal verificado
    Weston, United States
  • Site 6
    Código postal verificado
    Wheaton, United States

Preguntas comunes

¿Qué es el Angioedema Hereditario (HAE)?

HAE is a rare genetic condition that causes sudden, unpredictable swelling in different parts of your body, like your skin, bowels, or throat.

What is a 'Phase 3' clinical trial?

It's one of the final stages of testing a new medicine, involving many people, to confirm its safety and effectiveness before it might be made available to everyone.

¿Qué es un 'placebo'?

A placebo looks exactly like the study medicine but contains no active ingredients. It helps researchers understand if the new medicine is truly effective.

¿Sabré si estoy recibiendo el medicamento real o el placebo?

No, neither you nor your study doctor will know. This is called 'double-blind' and helps ensure the study results are accurate and fair.

What is 'navenibart'?

Navenibart is the name of the new investigational medicine being tested in this study to prevent HAE attacks.

Cómo obtener más información

Siempre hable con su médico de cabecera o especialista antes de decidir participar en un estudio.

Discusión

Discusión comunitaria

Impulsado por nuestro foro en community.patient.info. Por favor, sea respetuoso — esto no es un consejo médico.